Organogenesis names new chief financial officer

February 17, 2021 By Danielle Kirsh

Organogenesis this week said it appointed David Francisco as the company’s chief financial officer, effective Feb. 15.

Francisco replaces Henry Hagopian, who will move on to become the company’s senior VP of finance and treasurer.

“I am pleased to welcome Dave to the Organogenesis executive leadership team,” president and CEO Gary Gillheeney said in a news release. “Dave brings strong strategic, financial, and operational leadership across multiple business areas and over 25 years of finance and accounting experience. I look forward to working with Dave as we continue to execute on our strategy to drive growth and improve profitability while delivering on our mission to substantially improve medical outcomes and lower the overall cost of care.”

Prior to joining the company, Francisco held leadership roles at PerkinElmer.

“Organogenesis is an impressive organization with compelling growth opportunities,” Francisco said. “I am excited to join the Company at a time that I believe represents an important inflection point in its history and look forward to partnering with Gary and the rest of the executive leadership team to deliver strong operational and financial performance.”

Tegra Medical announces new director of sales and marketing in Europe
Tegra Medical announced that it appointed Darren Vine as its director of sales and marketing in Europe. Franklin, Mass.-based Tegra said in a news release that Vine will report to CEO and head of SFS division medical Walter Kobler, with responsibilities including the building of the company’s presence through expansion into new markets around the… […]
5 challenges Boston Scientific overcame to make single-use scopes work
FDA wanted single-use scopes to reduce potentially deadly superbug infections. Here’s how Boston Scientific made it happen. Boston Scientific’s Exalt Model D Single-Use Duodenoscope received FDA clearance in December 2019. It was the first device of its kind to hit the medical market. Just five months earlier, the FDA urged device manufacturers to move away from re-usable duodenoscopes with… […]
Veranex acquires Experien Group
Veranex announced today that it acquired Experien Group, a provider of regulatory, quality and clinical consulting services for medtech companies. Raleigh, N.C.-based Veranex, which was created as a combination of companies after Summit Partners acquired Ximedica, Quartesian and Boston Healthcare Associates in June, offers integrated product development strategies and services to medtech companies. According to… […]
How Olympus is using AI to find patients for its COPD device
Olympus recently announced its SeleCT Connect program, which uses diagnostic imaging AI to automatically screen which people might benefit from its Spiration valve system. Spiration is an FDA-designated breakthrough device for treating chronic obstructive pulmonary disease (COPD) patients. SeleCT Connect — offered as part of Olympus’ SeleCT quantitative computer tomography (QCT) analysis service — is… […]
Catheter & Medical Design and VitalDyne Medical rebrand as VitalPath
Catheter & Medical Design and VitalDyne Medical — makers of complex medical catheter systems — have rebranded under the name VitalPath. The move comes about five months after CMD’s March 2021 acquisition of VitalDyne. The Roseville, Minn.–based company also has a new website at vitalpath.com. VitalPath will exhibit at booth No. 1714 at MD&M West,… […]
Dymax touts newest formulations for medtech wearables
Dymax is using MD&M West in Anaheim, Calif. next week to tout its newest formulations for assembling medical device wearables. The Dymax materials are free from IBOA and TPO, are compatible with common and difficult substrates, and have passed ISO 10993-10 for sensitization and irritation, according to the Torrington, Conn.–based company. For manufacturers involved with… […]
What is a proportional isolation valve?
A “proportional” isolation valve can bring the next level of control and design for engineers, especially in life science industries. Doug Paynter, Clippard When we talk about proportional valves, whether they are pneumatic or hydraulic, we typically refer to valves that vary their flow path when you apply an increasing or decreasing amount of power/current… […]
CoorsTek scores EU legal win in pink components trademark dispute
The EU Trademark Court of Appeals in Paris recently upheld a Paris EU Trademark High Court decision that sided with CoorsTek against CeramTec in a trademark dispute over “pink” ceramic hip components. The Paris Court of Appeals in its June 2021 ruling upheld the cancelations of the three EU trademarks and the dismissal of CeramTec’s… […]
Abbott CMO Dr. Nick West touts latest iteration of drug-eluting stent
Abbott executive Dr. Nick West believes the company offers the “best-in-class” drug-eluting stent with its Xience platform. When Abbott (NYSE:ABT) CMO & divisional VP of global medical affairs Dr. Nick West looks back at his use of drug-eluting stents in the early 2000s, all he sees now is innovation. As a practicing interventional cardiologist, West remembers… […]
Versapor® RC Membranes: The next generation of venting materials
As the world leader in the design and production of membranes, filtration devices, and separation systems, Pall Corporation supplies products to nearly every industry in the world. Founded in 1946, Pall Corporation has set the standard for filtration solutions for 75 years and counting. Our customers have relied on us for their most sophisticated applications… […]
Tips to help bring your medical device from mind to market
By Bret Ludwig, Ph.D. Senior Product Development Specialist, 3M Medical Materials & Technologies Great medical devices start with an idea—a spark. And from there, it might move to the back of a napkin or a notepad. But as development continues, the process can get trickier and more complex. In fact, turning an idea into a… […]